Warren Bickel

Warren Bickel is an addiction researcher whose work gives the book a way to measure one of opioid addiction’s defining distortions: the shrinking of the future. He compared the way people with and without addiction perceive time, and hoped that research could help people at risk extend their outlook before addiction took hold. The narrative values that scientific ambition while asking how it might reach people facing urgent needs in the present. Later, Bickel pursued a practical route from research to treatment through a project linking emergency care with outpatient Medication-assisted treatment.

Research and the shrinking future

Bickel, who was working in Baltimore, Maryland, by the mid-2000s, studied opioid use and the way people weigh future outcomes. In the book, his research gives a quantitative shape to a pattern also visible in stories of people who use opioids: the immediate need to avoid withdrawal can overwhelm concerns that would otherwise govern a person’s decisions. The narrative places this pattern within a larger cycle in which people may move from prescription drugs to heroin and, to finance continued use, recruit others into selling or using. Bickel’s work does not explain that whole network, but helps clarify the powerful pull of immediate relief within it.

His comparison of time horizons made the contrast stark. The average person without addiction perceived the future as extending about 4.7 years; the average addicted participant’s horizon was just nine days. The measure translated an abstract idea, Temporal discounting in addiction, into a difference of scale: decisions and consequences separated by years could lose force beside what might happen over the coming days. In the book’s account, this helps explain why information about long-term harm may not compete effectively with the immediate threat of withdrawal. The finding describes a tendency, not a complete portrait of any one person, but it gives the narrative a vocabulary for the pressure exerted by the present.

Prediction, prevention, and the limits of a model

In a 2016 interview, Bickel said he hoped to develop methods that could predict future addictive behavior among children and help those at risk improve and extend their temporal outlook. The ambition joined prediction to prevention: research might identify vulnerability, but it might also give people a stronger ability to take the future into account. The proposed goal was not simply to classify risk, but to change the outlook that could leave someone exposed to it.

The reporting nevertheless tests the distance between a measurable pattern and the lives it is meant to help. Bickel had won prestigious grants and awards and was described as a rising figure in the expanding research community. Yet the book’s narrator struggled to see how his findings applied to people nearby whose circumstances demanded immediate survival decisions. That question sharpens when the narrative asks whether an app designed around Bickel’s research could have prevented Jesse Bolstridge’s death. The book supplies no answer that converts that possibility into certainty. Instead, it makes the question a measure of the gap between promising research and the specific losses that give the research its stakes.

When asked where hope might be found, Bickel pointed to a framed Chinese proverb that urges lighting a candle rather than cursing the darkness. In context, the gesture does not resolve the narrator’s doubt about whether research can reach people in crisis. It offers a principle for continuing to work without pretending that a scientific insight, by itself, can overcome the conditions confronting those at risk.

From research to treatment

By 2017, Bickel was leading a more immediate effort at the Virginia Tech Carilion Research Institute. He had secured a $1 million grant to pilot new Medication-assisted treatment protocols intended to make the transition from emergency departments to outpatient care more efficient. The plan connected patients who had overdosed directly to outpatient buprenorphine treatment, including through Sublocade, a newly approved once-monthly injection. In this account, his research work thus extends beyond explaining behavior: it also addresses how a patient might be connected to ongoing treatment after an emergency.

A recent overdose death among Bickel’s acquaintances gave this work a personal urgency. The young man had been taking Suboxone, but after a follow-up test detected additional opioids, his doctor reduced the medication dose as punishment. Bickel argued that the patient needed a higher dose rather than a lower one. The episode sets two approaches to treatment against each other: a response that treats continued opioid use as grounds for penalty, and one that understands it as a reason to sustain or strengthen care.

Bickel referred to a study he had coauthored in 1988. It found that buprenorphine protected people with opioid addiction from overdose death and was associated with reduced crime and better health. Though the research was decades old, he said, its implications remained insufficiently understood. The old study and the new emergency-to-outpatient project form a pointed contrast: evidence of benefit had existed for years, while knowledge of it and access to treatment still lagged.

The surrounding treatment gap

The book places Bickel’s initiatives within a fragmented local system. The Roanoke Community Services Board had added Medication-assisted treatment for twenty-one patients, but required them to engage in counseling first; Carilion Clinic had a three-week wait for outpatient treatment. At a Carilion-sponsored forum, the narrator proposed that physicians who had accepted benefits from Purdue Pharma should feel morally compelled to become authorized to prescribe Suboxone, potentially increasing treatment capacity. The doctors present responded with silence. The scene does not establish Bickel’s responsibility for those institutional barriers, but it shows the environment in which his proposed protocols would have to operate.

Bickel’s role in the narrative therefore rests on both the precision and the incompleteness of research. His figures make the narrowed time horizon of opioid addiction legible; his prevention ambitions seek to enlarge it; and his later treatment project attempts to improve the path from overdose care to continuing support. The book preserves the tension between these efforts and the lives they are meant to reach. A model can identify a powerful pattern, and a protocol can propose a route into care, but neither guarantees that a person in danger will receive the treatment needed.